Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Yu‑Fa Li"'
Autor:
Zhi‐Yong Chen, Rui Fu, Xiao‐Yue Tan, Li‐Xu Yan, Wen‐Fang Tang, Zhen‐Bin Qiu, Yi‐Fan Qi, Yu‐Fa Li, Qing‐Yi Hou, Yi‐Long Wu, Wen‐Zhao Zhong, Ben‐Yuan Jiang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 17, Pp 2524-2531 (2022)
Abstract Major pathological response (MPR) is a potential surrogate for overall survival. We determined whether the dynamic changes in 18F‐labeled fluoro‐2‐deoxyglucose positron emission tomography/computed tomography (18F‐FDG PET/CT) were as
Externí odkaz:
https://doaj.org/article/3841472ed6af42abb788c3d316d0684a
Autor:
Qing-Yun Gao, Fa-Man Xiao, Xiao-Cheng Lin, Yu-Qing Chen, Yu-Fa Li, Chang Lu, Jun-Wei Su, Quan-Quan Tan, Chan-Yuan Zhang, Jiao Yang, Yi-Long Wu, Hua-Jun Chen, Jin-Ji Yang
Publikováno v:
Cancer Treatment and Research Communications, Vol 35, Iss , Pp 100707- (2023)
Background: For patients with lung malignancies with RET rearrangement, the efficacy of immune checkpoint inhibitors is limited. The characteristics of the tumour immune microenvironment (TIME) and molecular pathological features of these patients ha
Externí odkaz:
https://doaj.org/article/023d31908c7f494ca5ccddf450d9803c
Autor:
Yu-Qing Chen, Ling-Ling Gao, Ling-Cong Kong, Xu-Hui Guan, Huan Yang, Yu-Fa Li, Zhi-Yi Lv, Xu-Chao Zhang, Hui-Ying Liang, Hua-Jun Chen, Yi-Long Wu, Jie Huang, Jin-Ji Yang
Publikováno v:
Cancer Treatment and Research Communications, Vol 35, Iss , Pp 100684- (2023)
Introduction: Recently, several clinical trials of immunotherapy for extensive-stage small-cell lung cancer (ES-SCLC) have shown limited benefits because of unselected patients. Thus, we aimed to explore whether YES-associated protein 1 (YAP-1) and P
Externí odkaz:
https://doaj.org/article/34561e2ac920400c816763499ae46027
Autor:
Yu-Qing Chen, BD, Yu-Fa Li, MD, Chan-Yuan Zhang, MD, Shi-Ling Zhang, BD, Zhi-Yi Lv, PhD, Song Dong, PhD, Hua-Jun Chen, PhD, Xu-Chao Zhang, PhD, Yi-Long Wu, MD, Jin-Ji Yang, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 12, Pp 100258- (2021)
Introduction: Pulmonary atypical carcinoid (PAC) is a rare subtype of pulmonary neuroendocrine neoplasm. Although EML4-ALK fusion has been detected in PAC, EGFR mutations have not been reported before. Methods: We performed hematoxylin and eosin stai
Externí odkaz:
https://doaj.org/article/feed2174255e4297a73cd4246748ccd1
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background Hepatocellular carcinoma (HCC) often arises in the setting of chronic inflammation with multiple inhibitory immune signals. V-domain Ig suppressor of T cell activation (VISTA) is identified as a novel negative checkpoint regulator
Externí odkaz:
https://doaj.org/article/6f7a526cf38741ba8470c241ef0d681b
Autor:
Zhong-Yi Dong, Jia-Tao Zhang, Si-Yang Liu, Jian Su, Chao Zhang, Zhi Xie, Qing Zhou, Hai-Yan Tu, Chong-Rui Xu, Li-Xu Yan, Yu-Fa Li, Wen-Zhao Zhong, Yi-Long Wu
Publikováno v:
OncoImmunology, Vol 6, Iss 11 (2017)
Patients with EGFR mutations showed unfavorable response to programmed cell death-1 (PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying association between EGFR mutation and immune resistance remains largely unclea
Externí odkaz:
https://doaj.org/article/80911abbd5ac4f668f55d7888ea6f51d
Autor:
Chan-Yuan, Zhang, Hao, Sun, Jun-Wei, Su, Yu-Qing, Chen, Shi-Ling, Zhang, Ming-Ying, Zheng, Yu-Fa, Li, Jie, Huang, Chao, Zhang, Zai-Xian, Tai, Miao, Cai, Xu-Chao, Zhang, Jian, Su, Chong-Rui, Xu, Hong-Hong, Yan, Hua-Jun, Chen, Yi-Long, Wu, Jin-Ji, Yang
Publikováno v:
Lung Cancer. 175:68-78
Transformed small-cell lung cancer (T-SCLC) has an extremely poor prognosis, and no remedies based on immunotherapy have been evaluated among T-SCLC patients. We retrospectively analysed the efficacy and safety of combining atezolizumab with chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de6040e24edab9d7001014af6e36ea39
https://doi.org/10.1016/j.lungcan.2022.11.016
https://doi.org/10.1016/j.lungcan.2022.11.016
Autor:
Qing-Yun Gao, Fa-Man Xiao, Xiao-cheng Lin, Yu-Qing Chen, Yu-Fa Li, Chang Lu, Jun-Wei Su, Quan-Quan Tan, Chan-Yuan Zhang, Jiao Yang, Yi-Long Wu, Hua-Jun Chen, Jin-Ji Yang
Purpose For patients with lung malignancies with RET rearrangement, the efficacy of immune checkpoint inhibitors is limited. The characteristics of the tumour immune microenvironment (TIME) and molecular pathological features of these patients have n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31eac47eb256797e769b45c9502082fc
https://doi.org/10.21203/rs.3.rs-2397760/v1
https://doi.org/10.21203/rs.3.rs-2397760/v1
Publikováno v:
Transactions of Nonferrous Metals Society of China. 30:1849-1856
In situ TiB2/Cu composites were fabricated by both solid−liquid (S−L) and liquid−liquid (L−L) reactive spray deposition in combination with cold rolling and annealing. The microstructure and properties of the fabricated TiB2/Cu composites wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3251f0c3099a02725a40024d88a90fa5
https://doi.org/10.1016/s1003-6326(20)65344-4
https://doi.org/10.1016/s1003-6326(20)65344-4
Autor:
Han-Min Wang, Chan-Yuan Zhang, Kai-Cheng Peng, Ze-Xin Chen, Jun-Wei Su, Yu-Fa Li, Wen-Feng Li, Qing-Yun Gao, Shi-Ling Zhang, Yu-Qing Chen, Qing Zhou, Cong Xu, Chong-Rui Xu, Zhen Wang, Jian Su, Hong-Hong Yan, Xu-Chao Zhang, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang
Publikováno v:
Cell Reports Medicine. 4:100911
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2643ef6370e78af9d9e06bb66c709997
https://doi.org/10.1016/j.xcrm.2022.100911
https://doi.org/10.1016/j.xcrm.2022.100911